It is not particularly surprising that in our cohort analysis we failed to detect an association between male FHS7-positive status and cancer incidence, since BRCA1/2-positive male individuals are known to have a lower cancer risk than BRCA1/2-positive female individuals. Here, BRCA1 is linked to cancer.